Status:

TERMINATED

Study on Functional Electrical Stimulation (FES) Cycling Following Spinal Cord Injury

Lead Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Conditions:

Spinal Cord Injury

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

This research is being done to study the effect of Functional Electrical Stimulation (FES) cycling on factors in blood and spinal cord in people with spinal cord injury (SCI).

Detailed Description

FES cycling is a method of applying low level electrical currents to the leg and buttock muscles to cause the weakened or paralyzed muscles to contract and produce a cycling motion of the legs. The FE...

Eligibility Criteria

Inclusion

  • History of traumatic spinal cord injury sustained at least 6 months prior
  • Complete spinal cord injury at any level American Spinal Injury Association (ASIA) impairment scale A
  • No use of functional electrical stimulation within 3 months
  • Medically stable, with no recent (1 month or less) inpatient admission for acute medical or surgical issues
  • Legally able to make own health care decisions

Exclusion

  • Cardiovascular disease as defined by previous myocardial infarction, unstable angina, requirement for anti platelet agents, congestive heart failure, or stroke, history of arrhythmia with hemodynamic instability
  • Uncontrolled hypertension (resting systolic blood pressure (BP) \>160mmHg or diastolic BP \>100mmHg consistently)
  • Concurrent lower motor neuron disease such as peripheral neuropathy that would exclude lower extremity electrical excitability
  • Unstable long bone fractures of the lower extremities
  • Subjects who are unwilling to agree to two (2) CSF examinations (lumbar punctures)
  • Presence of cardiac pacemaker and/or defibrillator
  • Presence of cancer
  • History of epileptic seizures
  • Subjects having a Stage 2 or greater sacral decubitus ulcer
  • Women who are pregnant
  • Active drug or alcohol use or dependence

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT01217047

Start Date

October 1 2010

End Date

August 1 2013

Last Update

January 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kennedy Krieger Institute

Baltimore, Maryland, United States, 21205